Q2 Solutions Collaborates with Illumina

Published on: October 26, 2016

Q2 Solutions, a global clinical trials laboratory services organization, has come to an agreement with Illumina, a global genomics provider.

Q2 Solutions, a global clinical trials laboratory services organization, has come to an agreement with Illumina, a global genomics provider. Under this agreement, the companies will establish a framework for developing next-generation sequencing-based (NGS) CDx assays.

Read the full release here